A.O. RUBANENKO | Практическая медицина

VKORC1 CC genotype is associated with activation of the coagulation cascade and reduction of fibrinolytic activity in patients with atrial fibrillation.

Редакция | 2015, PM Cardiology, Practical medicine 03 (15) Cardiology. Rheumatology. Part 2 | Май 26, 2015

A.O. RUBANENKO, YU.V. SCHUKIN Samara State Medical University, 89 Chapaevskaya St., Samara, Russian Federation, 443099 Rubanenko A.O. — Cand. of Med. Sc., Assistant of the Department of Propaedeutic Therapy, tel. +7-927-201-09-44, e-mail: [email protected] Schukin Yu.V. — D. Med. Sc., Head of the Department of Propaedeutic Therapy, tel. +7-927-262-09-03, e-mail: [email protected] This article is related to […]

Tag: A.O. RUBANENKO, atrial fibrillation, genetic polymorphisms, hemostasis, Practical medicine 03 (15) Cardiology. Rheumatology. Part 2, subunit 1 (VKORC1), thrombin-activatable fibrinolysis inhibitor (TAFI), vitamin К epoxide reductase complex, YU.V. SCHUKIN

Комментарии отключены

Articles. Working with contents

VKORC1 CC genotype is associated with activation of the coagulation cascade and reduction of fibrinolytic activity in patients with atrial fibrillation.

Find

PARTNERS